GENBGenerate Biomedicines, Inc.

$16.15

Who owns GENB

56 institutions reported holding GENB for 2026Q1, together 143% of the company.

56

Institutions reporting a position · as of 2026Q1

Shares held by institutions
92.8M

Shares held by institutions · 143% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.16B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
55 / 0

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
1
New positions
55
Positions exited
0
Added to
0
Reduced
0
Largest reported holders, 2026Q1
HolderShares% of companyValue
Flagship Ventures Management, Inc.62.7Mn/a$783M
FMR LLC4.2Mn/a$53M
Capital World Investors4.0Mn/a$50M
BRAIDWELL LP3.6Mn/a$45M
JPMORGAN CHASE & CO2.9Mn/a$34M
PRICE T ROWE ASSOCIATES INC /MD/2.1Mn/a$26M
ARCH Venture Management, LLC1.9Mn/a$24M
HarbourVest Partners LLC1.7Mn/a$22M
BAKER BROS. ADVISORS LP1.4Mn/a$18M
HARVARD MANAGEMENT CO INC1.1Mn/a$14M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…